Catasys, Inc. (NASDAQ:CATS) has been given an average broker rating score of 2.00 (Buy) from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy recommendation. Catasys’ rating score has declined by 33.3% from 90 days ago as a result of a number of analysts’ ratings changes.
Analysts have set a 12-month consensus target price of $5.30 for the company and are anticipating that the company will post ($0.09) earnings per share for the current quarter, according to Zacks. Zacks has also given Catasys an industry rank of 179 out of 265 based on the ratings given to related companies.
CATS has been the topic of several recent analyst reports. Zacks Investment Research downgraded shares of Catasys from a “hold” rating to a “sell” rating in a research report on Tuesday, December 19th. ValuEngine downgraded shares of Catasys from a “hold” rating to a “sell” rating in a research report on Saturday, October 21st. Taglich Brothers initiated coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “speculative buy” rating and a $8.00 price objective on the stock. Finally, Telsey Advisory Group initiated coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “buy” rating on the stock.
Catasys (NASDAQ:CATS) last announced its quarterly earnings data on Tuesday, November 14th. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.15) by ($0.04). analysts predict that Catasys will post -0.89 earnings per share for the current year.
A hedge fund recently bought a new stake in Catasys stock. UBS Oconnor LLC purchased a new stake in Catasys, Inc. (NASDAQ:CATS) during the second quarter, according to its most recent filing with the SEC. The fund purchased 182,597 shares of the company’s stock, valued at approximately $834,000. UBS Oconnor LLC owned about 1.15% of Catasys as of its most recent filing with the SEC. 6.39% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Brokerages Set $5.30 Target Price for Catasys, Inc. (CATS)” was published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3148022/brokerages-set-5-30-target-price-for-catasys-inc-cats.html.
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company?s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.